435 related articles for article (PubMed ID: 8646406)
1. Spontaneous rearrangement of aminoalkylisothioureas into mercaptoalkylguanidines, a novel class of nitric oxide synthase inhibitors with selectivity towards the inducible isoform.
Southan GJ; Zingarelli B; O'Connor M; Salzman AL; Szabó C
Br J Pharmacol; 1996 Feb; 117(4):619-32. PubMed ID: 8646406
[TBL] [Abstract][Full Text] [Related]
2. Pharmacological characterization of guanidinoethyldisulphide (GED), a novel inhibitor of nitric oxide synthase with selectivity towards the inducible isoform.
Szabó C; Bryk R; Zingarelli B; Southan GJ; Gahman TC; Bhat V; Salzman AL; Wolff DJ
Br J Pharmacol; 1996 Aug; 118(7):1659-68. PubMed ID: 8842429
[TBL] [Abstract][Full Text] [Related]
3. Potent inhibition of the inducible isoform of nitric oxide synthase by aminoethylisoselenourea and related compounds.
Southan GJ; Salzman AL; Szabo C
Life Sci; 1996; 58(14):1139-48. PubMed ID: 8614265
[TBL] [Abstract][Full Text] [Related]
4. The inhibitory effects of mercaptoalkylguanidines on cyclo-oxygenase activity.
Zingarelli B; Southan GJ; Gilad E; O'Connor M; Salzman AL; Szabó C
Br J Pharmacol; 1997 Feb; 120(3):357-66. PubMed ID: 9031736
[TBL] [Abstract][Full Text] [Related]
5. Isothioureas: potent inhibitors of nitric oxide synthases with variable isoform selectivity.
Southan GJ; Szabó C; Thiemermann C
Br J Pharmacol; 1995 Jan; 114(2):510-6. PubMed ID: 7533622
[TBL] [Abstract][Full Text] [Related]
6. Glibenclamide-induced inhibition of the expression of inducible nitric oxide synthase in cultured macrophages and in the anaesthetized rat.
Wu CC; Thiemermann C; Vane JR
Br J Pharmacol; 1995 Mar; 114(6):1273-81. PubMed ID: 7542532
[TBL] [Abstract][Full Text] [Related]
7. Characterization of the effects of two new arginine/citrulline analogues on constitutive and inducible nitric oxide synthases in rat aorta.
Joly GA; Narayanan K; Griffith OW; Kilbourn RG
Br J Pharmacol; 1995 Jun; 115(3):491-7. PubMed ID: 7582462
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of nitric oxide synthase by 1-(2-trifluoromethylphenyl) imidazole (TRIM) in vitro: antinociceptive and cardiovascular effects.
Handy RL; Harb HL; Wallace P; Gaffen Z; Whitehead KJ; Moore PK
Br J Pharmacol; 1996 Sep; 119(2):423-31. PubMed ID: 8886430
[TBL] [Abstract][Full Text] [Related]
9. Amidines are potent inhibitors of nitric oxide synthases: preferential inhibition of the inducible isoform.
Southan GJ; Szabó C; Connor MP; Salzman AL; Thiemermann C
Eur J Pharmacol; 1995 Nov; 291(3):311-8. PubMed ID: 8719415
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of nitric oxide synthase with pyrazole-1-carboxamidine and related compounds.
Southan GJ; Gauld D; Lubeskie A; Zingarelli B; Cuzzocrea S; Salzman AL; Szabó C; Wolff DJ
Biochem Pharmacol; 1997 Aug; 54(3):409-17. PubMed ID: 9278100
[TBL] [Abstract][Full Text] [Related]
11. Comparison of the inhibitory effect of isothiourea and mercapto-alkylguanidine derivatives on the alternative pathways of arginine metabolism in macrophages.
Hrabák A; Bajor T; Southan GJ; Salzman AL; Szabó C
Life Sci; 1997; 60(26):PL395-401. PubMed ID: 9199488
[TBL] [Abstract][Full Text] [Related]
12. Attenuation of endotoxin-induced multiple organ dysfunction by 1-amino-2-hydroxy-guanidine, a potent inhibitor of inducible nitric oxide synthase.
Ruetten H; Southan GJ; Abate A; Thiemermann C
Br J Pharmacol; 1996 May; 118(2):261-70. PubMed ID: 8735625
[TBL] [Abstract][Full Text] [Related]
13. Characterization of the induction of nitric oxide synthase and cyclo-oxygenase in rat aorta in organ culture.
Bishop-Bailey D; Larkin SW; Warner TD; Chen G; Mitchell JA
Br J Pharmacol; 1997 May; 121(1):125-33. PubMed ID: 9146896
[TBL] [Abstract][Full Text] [Related]
14. Modulation of IL-1-induced cartilage injury by NO synthase inhibitors: a comparative study with rat chondrocytes and cartilage entities.
Cipolletta C; Jouzeau JY; Gegout-Pottie P; Presle N; Bordji K; Netter P; Terlain B
Br J Pharmacol; 1998 Aug; 124(8):1719-27. PubMed ID: 9756389
[TBL] [Abstract][Full Text] [Related]
15. Aminoguanidine attenuates the delayed circulatory failure and improves survival in rodent models of endotoxic shock.
Wu CC; Chen SJ; Szabó C; Thiemermann C; Vane JR
Br J Pharmacol; 1995 Apr; 114(8):1666-72. PubMed ID: 7541282
[TBL] [Abstract][Full Text] [Related]
16. Selective pharmacological inhibition of distinct nitric oxide synthase isoforms.
Southan GJ; Szabó C
Biochem Pharmacol; 1996 Feb; 51(4):383-94. PubMed ID: 8619882
[TBL] [Abstract][Full Text] [Related]
17. Expression of constitutive and inducible nitric oxide synthases in the vascular wall of young and aging rats.
Cernadas MR; Sánchez de Miguel L; García-Durán M; González-Fernández F; Millás I; Montón M; Rodrigo J; Rico L; Fernández P; de Frutos T; Rodríguez-Feo JA; Guerra J; Caramelo C; Casado S; López-Farré
Circ Res; 1998 Aug; 83(3):279-86. PubMed ID: 9710120
[TBL] [Abstract][Full Text] [Related]
18. The multiple organ dysfunction syndrome caused by endotoxin in the rat: attenuation of liver dysfunction by inhibitors of nitric oxide synthase.
Thiemermann C; Ruetten H; Wu CC; Vane JR
Br J Pharmacol; 1995 Dec; 116(7):2845-51. PubMed ID: 8680715
[TBL] [Abstract][Full Text] [Related]
19. Endothelium-dependent vascular hyporesponsiveness without detection of nitric oxide synthase induction in aortas of cirrhotic rats.
Weigert AL; Martin PY; Niederberger M; Higa EM; McMurtry IF; Gines P; Schrier RW
Hepatology; 1995 Dec; 22(6):1856-62. PubMed ID: 7489998
[TBL] [Abstract][Full Text] [Related]
20. Co-induction of nitric oxide synthase and cyclo-oxygenase: interactions between nitric oxide and prostanoids.
Swierkosz TA; Mitchell JA; Warner TD; Botting RM; Vane JR
Br J Pharmacol; 1995 Apr; 114(7):1335-42. PubMed ID: 7541688
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
